As of 2024-12-12, the Fair Value of Esperion Therapeutics Inc (ESPR) is -2.20 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.69 USD, the upside of Esperion Therapeutics Inc is -181.85%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -97.20 | -143.60 | -269.10 | -233.70 | -209.25 | -190.57 |
| YoY growth | 51.83% | -47.74% | -87.40% | 13.15% | 10.46% | -11.94% |
| Market Cap (mil) | 667.78 |
| P/E | |
| Forward P/E |
| EPS | -0.44 |
| Avg earnings growth rate | -11.94% |
| TTM earnings | -86.77 |